Literature DB >> 3045310

Feverfew--an ancient remedy for modern times?

S Heptinstall1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3045310      PMCID: PMC1291660          DOI: 10.1177/014107688808100701

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  10 in total

1.  The activity of compounds extracted from feverfew on histamine release from rat mast cells.

Authors:  N A Hayes; J C Foreman
Journal:  J Pharm Pharmacol       Date:  1987-06       Impact factor: 3.765

2.  Investigation of possible genetoxic effects of feverfew in migraine patients.

Authors:  E S Johnson; N P Kadam; D Anderson; P C Jenkinson; R S Dewdney; S D Blowers
Journal:  Hum Toxicol       Date:  1987-11

3.  Amounts of feverfew in commercial preparations of the herb.

Authors:  W A Groenewegen; S Heptinstall
Journal:  Lancet       Date:  1986-01-04       Impact factor: 79.321

4.  The effect of an aqueous extract of Tanacetum parthenium L. on arachidonic acid metabolism by rat peritoneal leucocytes.

Authors:  F Capasso
Journal:  J Pharm Pharmacol       Date:  1986-01       Impact factor: 3.765

5.  Extracts of feverfew inhibit granule secretion in blood platelets and polymorphonuclear leucocytes.

Authors:  S Heptinstall; A White; L Williamson; J R Mitchell
Journal:  Lancet       Date:  1985-05-11       Impact factor: 79.321

6.  Extracts of feverfew may inhibit platelet behaviour via neutralization of sulphydryl groups.

Authors:  S Heptinstall; W A Groenewegen; P Spangenberg; W Loesche
Journal:  J Pharm Pharmacol       Date:  1987-06       Impact factor: 3.765

7.  A platelet phospholipase inhibitor from the medicinal herb feverfew (Tanacetum parthenium).

Authors:  A N Makheja; J M Bailey
Journal:  Prostaglandins Leukot Med       Date:  1982-06

8.  Efficacy of feverfew as prophylactic treatment of migraine.

Authors:  E S Johnson; N P Kadam; D M Hylands; P J Hylands
Journal:  Br Med J (Clin Res Ed)       Date:  1985-08-31

9.  Extracts of feverfew inhibit mitogen-induced human peripheral blood mononuclear cell proliferation and cytokine mediated responses: a cytotoxic effect.

Authors:  L A O'Neill; M L Barrett; G P Lewis
Journal:  Br J Clin Pharmacol       Date:  1987-01       Impact factor: 4.335

10.  Compounds extracted from feverfew that have anti-secretory activity contain an alpha-methylene butyrolactone unit.

Authors:  W A Groenewegen; D W Knight; S Heptinstall
Journal:  J Pharm Pharmacol       Date:  1986-09       Impact factor: 3.765

  10 in total
  2 in total

Review 1.  Clinical pharmacology and therapeutics.

Authors:  M J Kendall; R C Horton
Journal:  Postgrad Med J       Date:  1990-03       Impact factor: 2.401

2.  Involvement of Akt/NF-κB pathway in antitumor effects of parthenolide on glioblastoma cells in vitro and in vivo.

Authors:  Hiromichi Nakabayashi; Keiji Shimizu
Journal:  BMC Cancer       Date:  2012-10-05       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.